BioMarin Pharmaceutical Inc (BMRN) Social Stream



BioMarin Pharmaceutical Inc (BMRN): $90.85

0.66 (-0.72%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add BMRN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#20 of 363

in industry

BIOMARIN PHARMACEUTICAL INC (BMRN) Price Targets From Analysts

Use the tables below to see what analysts covering BIOMARIN PHARMACEUTICAL INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 15 $152 $82 $108.642 $96 13.17%
2021-11-15 15 $152 $82 $108.928 $96 13.47%
2021-11-22 15 $152 $82 $109.357 $96 13.91%
2022-01-05 15 $155 $88 $111.5 $96 16.15%
2022-01-06 15 $155 $88 $112.214 $96 16.89%
2022-01-21 14 $155 $88 $112.571 $96 17.26%
2022-02-25 15 $155 $88 $112.857 $96 17.56%
2022-02-28 15 $155 $88 $115.75 $96 20.57%
2022-04-22 13 $155 $88 $116.25 $96 21.09%
2022-04-26 13 $155 $88 $117.666 $96 22.57%
2022-06-01 13 $147 $88 $116.833 $96 21.7%
2022-06-21 13 $136 $70 $110.416 $96 15.02%
2022-07-22 14 $140 $70 $111.23 $96 15.86%
2022-08-02 13 $140 $70 $113.166 $96 17.88%
2022-08-03 13 $140.001 $70 $113.166 $96 17.88%
2022-08-05 14 $140.001 $70 $114.769 $96 19.55%
2022-08-13 14 $140.001 $70 $115 $96 19.79%
2022-09-27 14 $140.001 $74 $115.384 $96 20.19%
2022-10-12 14 $140.001 $74 $115.769 $96 20.59%
2022-10-21 15 $140.001 $74 $113.857 $96 18.6%
2022-10-28 15 $135 $74 $111.857 $96 16.52%
2022-11-23 15 $135 $74 $113.142 $96 17.86%
2022-11-30 15 $135 $74 $114.571 $96 19.34%
2023-01-04 15 $135 $74 $115.285 $96 20.09%
2023-01-10 15 $200 $74 $121.142 $96 26.19%
2023-01-13 15 $200 $83 $121.785 $96 26.86%
2023-01-23 15 $200 $83 $122.142 $96 27.23%
2023-01-27 15 $200 $83 $123.5 $96 28.65%
2023-01-31 16 $200 $83 $122.4 $96 27.5%
2023-02-08 16 $200 $83 $122.933 $96 28.06%
2023-02-21 17 $200 $83 $122.5 $96 27.6%
2023-02-27 17 $200 $83 $123.333 $96 28.47%
2023-02-28 19 $200 $74 $123.235 $96 28.37%
2023-03-07 19 $200 $74 $123.176 $96 28.31%
2023-03-10 19 $200 $74 $122.588 $96 27.7%
2023-04-24 20 $200 $74 $120.277 $96 25.29%
2023-04-28 21 $200 $69 $119.5 $96 24.48%
2023-06-12 21 $200 $69 $119.315 $96 24.29%
2023-06-29 20 $200 $69 $119.333 $96 24.31%
2023-06-30 20 $200 $73 $119.555 $96 24.54%
2023-07-19 20 $200 $73 $118.166 $96 23.09%
2023-08-01 20 $185 $73 $117.333 $96 22.22%
2023-08-02 20 $185 $70 $115.882 $96 20.71%
2023-08-23 20 $185 $70 $115.882 $96 20.71%
2023-09-12 20 $185 $71 $115.941 $96 20.77%
2023-09-14 20 $185 $78 $116.352 $96 21.2%
2023-09-18 21 $185 $78 $116.555 $96 21.41%
2023-10-16 22 $185 $78 $116.555 $96 21.41%
2023-10-25 22 $185 $78 $116.611 $96 21.47%
2023-11-01 23 $185 $78 $116.315 $96 21.16%
2023-11-02 24 $185 $78 $113.5 $96 18.23%
2023-11-07 24 $170 $78 $112.15 $96 16.82%
2023-11-15 25 $170 $78 $110.952 $96 15.57%

The Trend in the Analyst Price Target


Over the past 29 months, BMRN's average price target has gone up $3.84.

Over the past 44 weeks, BMRN's average upside potential has been 28.35%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-13 15 200 83 121.785 112.72 8.04%
2023-06-12 21 200 69 119.315 93.32 27.86%
2023-07-24 20 185 73 117.333 87.41 34.23%
2023-08-23 19 185 70 115.882 91.07 27.24%
2023-09-14 20 185 78 116.352 87.68 32.7%

BMRN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.64 17 0 8 0 0 25

The Trend in the Broker Recommendations


BMRN's average broker recommendation rating worsened by 0.04 over the prior 35 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BMRN as an investment opportunity.

  • In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 5461.78% of that group.
  • In the context of Pharmaceutical Products stocks, BIOMARIN PHARMACEUTICAL INC's average analyst price target is higher than 5753.67% of them.
  • In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -5147.89% of that group.
  • In terms of how BIOMARIN PHARMACEUTICAL INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1600.43% of that group.

Stocks similar to BIOMARIN PHARMACEUTICAL INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NKTR, BHC, and VRTX.

Is BMRN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!